Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

In the first four months of 2026, three brain-computer interface companies earned FDA Breakthrough Device Designation, a ...

NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE)--Synchron, a brain computer interface company, today announced a Twitter takeover by Philip O’Keefe, one of the patients implanted with the Stentrode ...

These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...

When a new technology shows promise, performance-wise and commercially, innovation does not stop. To the contrary, it gathers pace. New medical devices typically emerge from competing groups of ...

Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Apple is set to develop a brain implant chip (aka a 'category-defining brain-computer interface' in tech terms) that will allow users to control their iPhone, iPad and Apple Vision Pro with just their ...